Hot Life Science Investor Mandate 19: Venture Capital Firm Seeking Late Stage Therapeutics Diagnostics and Devices

4 Jun

A venture capital firm based in the Western United States is looking to invests in growth and expansion-stage technology and life science companies. The firm is currently investing from its inaugural fund and expects to close its second fund ($50M target) by the end of 2014. The firm prefers to make growth stage investments in Series C and D rounds, typically co-investing with other institutional investors. The investment size is variable depending on the company’s market capitalization. The firm focuses on companies that are located in regions underserved by venture capital such and the firm is actively seeking new investment opportunities.

In the life sciences the firm seeks to invest in therapeutics, medical devices, and diagnostics. The firm is opportunistic in terms of subsectors and indications. The firm seeks therapeutics that are at least in Phase III and medical devices that are very close to or with FDA approval. The firm historically invested in vitro diagnostic tests and medical imaging.

The firm generally co-invests with other top tier institutional investors and seeks companies with a strong and experienced management team.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: